Angang Yang

127 Changle West Road
Xi'an, 710032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 98 publications

Correction: Anti-EGFR ScFv functionalized exosomes delivering LPCAT1 specific siRNAsfor inhibition of lung cancer brain metastases.

Correction: Anti-EGFR ScFv functionalized exosomes delivering LPCAT1 specific siRNAsfor inhibition of lung cancer brain metastases.

Journal: Journal of nanobiotechnology

Published: July 01, 2026

The niche-metabolism axis: reprogramming tumor-associated macrophages for precision immunotherapy.

The niche-metabolism axis: reprogramming tumor-associated macrophages for precision immunotherapy.

Journal: Trends in molecular medicine

Published: May 21, 2026

p53 hotspot mutants attenuate CTL-mediated tumor cell killing through a novel ALKBH5-YTHDF3-PD-L1 pathway.

p53 hotspot mutants attenuate CTL-mediated tumor cell killing through a novel ALKBH5-YTHDF3-PD-L1 pathway.

Journal: Oncogene

Published: November 26, 2025

Cholesterol metabolism: a new checkpoint in cancer immunity.

Cholesterol metabolism: a new checkpoint in cancer immunity.

Journal: Trends in molecular medicine

Published: September 25, 2025

Author Correction: SMAD7 expression in CAR-T cells improves persistence and safety for solid tumors.

Author Correction: SMAD7 expression in CAR-T cells improves persistence and safety for solid tumors.

Journal: Cellular & molecular immunology

Published: August 26, 2025

177Lu-Dotatate versus high-dose long-acting octreotide for the treatment of patients with advanced, grade 1-2, well-differentiated gastroenteropancreatic neuroendocrine tumours (XT-XTR008-3-01): an open-label, randomised, phase III trial.

177Lu-Dotatate versus high-dose long-acting octreotide for the treatment of patients with advanced, grade 1-2, well-differentiated gastroenteropancreatic neuroendocrine tumours (XT-XTR008-3-01): an open-label, randomised, phase III trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: July 07, 2025

METTL3 abrogation promotes glioma progression through regulating the ISG15-FASN axis-mediated lipid metabolism in macrophages.

METTL3 abrogation promotes glioma progression through regulating the ISG15-FASN axis-mediated lipid metabolism in macrophages.

Journal: Nature communications

Published: May 31, 2025

Lactylation in health and disease: physiological or pathological?

Lactylation in health and disease: physiological or pathological?

Journal: Theranostics

Published: October 17, 2024

Overexpression of miR-124 enhances the therapeutic benefit of TMZ treatment in the orthotopic GBM mice model by inhibition of DNA damage repair.

Overexpression of miR-124 enhances the therapeutic benefit of TMZ treatment in the orthotopic GBM mice model by inhibition of DNA damage repair.

Journal: Cell death & disease

Published: August 31, 2024

A novel role for endoplasmic reticulum protein ERp72 in the pathogenesis of autoantibody-induced arthritis.

A novel role for endoplasmic reticulum protein ERp72 in the pathogenesis of autoantibody-induced arthritis.

Journal: Scandinavian journal of rheumatology

Published: July 08, 2024

Epigenetic activation of JAG1 by AID contributes to metastasis of hepatocellular carcinoma.

Epigenetic activation of JAG1 by AID contributes to metastasis of hepatocellular carcinoma.

Journal: The Journal of biological chemistry

Published: May 18, 2024

In vitro and in vivo validation of cytotoxicity of targeting human epidermal growth factor receptor-2 chimeric antigen receptor T (HER2-CAR-T) cells

In vitro and in vivo validation of cytotoxicity of targeting human epidermal growth factor receptor-2 chimeric antigen receptor T (HER2-CAR-T) cells

Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology

Published: May 06, 2024

Showing 1-12 of 98

Last Updated: 09/26/2026